Literature DB >> 33420916

Clinical Outcomes, Trends in Weight, and Weight Loss Strategies in Patients With Obesity After Durable Ventricular Assist Device Implantation.

Naga Vaishnavi Gadela1, Devika Umashanker2, Andrew Scatola3, Abhishek Jaiswal4.   

Abstract

PURPOSE OF REVIEW: To discuss clinical outcomes, changes in weight, and weight loss strategies of patients with obesity post left ventricular assist device (LVAD) implantation. RECENT
FINDINGS: Despite increased complications in patients with obesity after LVAD implantation, survival is comparable to patients without obesity. A minority of patients with obesity lose significant weight and become eligible for heart transplantation after LVAD implantation. In fact, a great majority of such patients gain weight post-implantation. Obesity by itself should not be considered prohibitive for LVAD therapy but, rather, should be incorporated into the overall risk assessment for LVAD implantation. Concerted strategies should be developed to promote sustainable weight loss in patients with obesity and LVAD to improve quality of life, eligibility, and outcomes after heart transplantation. Investigation of the long-term impact of weight loss on patients with obesity with LVAD is warranted.

Entities:  

Keywords:  Anti-obesity medication; Bariatric surgery; Heart transplantation; Lifestyle modification; Obesity; Ventricular assist device; Weight loss

Year:  2021        PMID: 33420916     DOI: 10.1007/s11897-020-00500-z

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  63 in total

1.  The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update.

Authors:  Mandeep R Mehra; Charles E Canter; Margaret M Hannan; Marc J Semigran; Patricia A Uber; David A Baran; Lara Danziger-Isakov; James K Kirklin; Richard Kirk; Sudhir S Kushwaha; Lars H Lund; Luciano Potena; Heather J Ross; David O Taylor; Erik A M Verschuuren; Andreas Zuckermann
Journal:  J Heart Lung Transplant       Date:  2016-01       Impact factor: 10.247

2.  Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss.

Authors:  M A Alpert; B E Terry; M Mulekar; M V Cohen; C V Massey; T M Fan; H Panayiotou; V Mukerji
Journal:  Am J Cardiol       Date:  1997-09-15       Impact factor: 2.778

3.  Impact of Obesity on Ventricular Assist Device Outcomes.

Authors:  Abhishek Jaiswal; Lauren K Truby; Astha Chichra; Rashmi Jain; Leann Myers; Nirav Patel; Veli K Topkara
Journal:  J Card Fail       Date:  2019-10-13       Impact factor: 5.712

Review 4.  Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.

Authors:  Biykem Bozkurt; David Aguilar; Anita Deswal; Sandra B Dunbar; Gary S Francis; Tamara Horwich; Mariell Jessup; Mikhail Kosiborod; Allison M Pritchett; Kumudha Ramasubbu; Clive Rosendorff; Clyde Yancy
Journal:  Circulation       Date:  2016-10-31       Impact factor: 29.690

5.  Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity.

Authors:  Zachary J Ward; Sara N Bleich; Angie L Cradock; Jessica L Barrett; Catherine M Giles; Chasmine Flax; Michael W Long; Steven L Gortmaker
Journal:  N Engl J Med       Date:  2019-12-19       Impact factor: 91.245

6.  Prevalence, Profile, and Prognosis of Severe Obesity in Contemporary Hospitalized Heart Failure Trial Populations.

Authors:  Emer Joyce; Anuradha Lala; Susanna R Stevens; Lauren B Cooper; Omar F AbouEzzeddine; John D Groarke; Justin L Grodin; Eugene Braunwald; Kevin J Anstrom; Margaret M Redfield; Lynne W Stevenson
Journal:  JACC Heart Fail       Date:  2016-12       Impact factor: 12.035

7.  Hypertension, Obesity, Diabetes, and Heart Failure-Free Survival: The Cardiovascular Disease Lifetime Risk Pooling Project.

Authors:  Faraz S Ahmad; Hongyan Ning; Jonathan D Rich; Clyde W Yancy; Donald M Lloyd-Jones; John T Wilkins
Journal:  JACC Heart Fail       Date:  2016-10-12       Impact factor: 12.035

8.  Bariatric surgery in patients with left ventricular assist devices: a safe and effective method of weight loss as a gateway to heart transplantation.

Authors:  Ariela Zenilman; David Pechman; Erin Moran-Atkin; Jenny Choi; Diego Camacho
Journal:  Surg Obes Relat Dis       Date:  2019-08-14       Impact factor: 4.734

9.  The Impact of Obesity on Patients Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices.

Authors:  Kevin J Clerkin; Yoshifumi Naka; Donna M Mancini; Paolo C Colombo; Veli K Topkara
Journal:  JACC Heart Fail       Date:  2016-09-07       Impact factor: 12.035

10.  Obesity and the risk of heart failure.

Authors:  Satish Kenchaiah; Jane C Evans; Daniel Levy; Peter W F Wilson; Emelia J Benjamin; Martin G Larson; William B Kannel; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245

View more
  3 in total

1.  Bariatric Surgery as the One Route to Achieving Donor Heart Transplantation in a Patient with a Left-Ventricular Assist Device.

Authors:  Clara Boeker; Ibrahim A Hakami; Julian Mall; Christian Reetz; Kamil Yamac; Hinrich Koehler
Journal:  Obes Facts       Date:  2021-12-10       Impact factor: 3.942

2.  Skeletal Muscle Mass Recovery Early After Left Ventricular Assist Device Implantation in Patients With Advanced Systolic Heart Failure.

Authors:  Amanda R Vest; William W Wong; Joronia Chery; Alex Coston; Laura Telfer; Matthew Lawrence; Didjana Celkupa; Michael S Kiernan; Gregory Couper; Masashi Kawabori; Edward Saltzman
Journal:  Circ Heart Fail       Date:  2022-04-05       Impact factor: 10.447

3.  Use of Cardiac Contractility Modulation as Bridge to Transplant in an Obese Patient With Advanced Heart Failure: A Case Report.

Authors:  Daniele Masarone; Andrea Petraio; Antonio Fiorentino; Santo Dellegrottaglie; Fabio Valente; Ernesto Ammendola; Gerardo Nigro; Giuseppe Pacileo
Journal:  Front Cardiovasc Med       Date:  2022-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.